Apple, Inc AAPL
S&P 500 ETF Trust SPDR SPY
Alphabet Inc. - Class A Shares GOOGL
Microsoft Corporation MSFT
Meta Platforms Inc META
Netflix, Inc. NFLX
Amazon.com Inc. AMZN
Spotify Technology SA SPOT

Nurix Therapeutics Inc Share Price

NRIX

NMQ

$15.64

+$0.04

(0.26%)

Industry: Biotechnology Sector: Health Care

Nurix Therapeutics Inc Analyst Forecast

Overview Returns Financials Ratios News FAQs

Nurix Therapeutics Inc Share Price Chart

Nurix Therapeutics Inc Key Stock Metrics

Market Cap info-icon

This is a company’s total value as determined by the stock market. It is calculated by multiplying the total number of a company's outstanding shares by the current market price of one share.

$1.60B

P/E Ratio

This is the ratio of a security’s current share price to its earnings per share. This ratio determines the relative value of a company’s share.

Volume

This is the total number of shares traded during the most recent trading day.

631.62K

Avg Volume info-icon

This is the average number of shares traded during the most recent 30 days.

Dividend Yield info-icon

This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).

0.00%

Beta

This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.

1.97

52-week Range info-icon

This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).

$8.18 L

$22.5 H

$15.64

About Nurix Therapeutics Inc, Common Stock

Nurix Therapeutics, Inc., a clinical stage biopharmaceutical company, focuses on the discovery, development, and commercialization of small molecule and antibody therapies for the treatment of cancer, inflammatory conditions, and other diseases. The company develops NX-5948, an orally bioavailable BTK degrader, that is in Phase 2 clinical trials for the treatment of relapsed or refractory B-cell malignancies and autoimmune diseases; NX-2127, an orally bioavailable Bruton's tyrosine kinase (BTK) degrader, that is in Phase Phase 1a/1b clinical trials for the treatment of relapsed or refractory B-cell malignancies; and NX-1607, an orally bioavailable Casitas B-lineage lymphoma proto-oncogene-B (CBL-B) inhibitor, that is in Phase 1a/1b clinical trials to treat immuno-oncology indications. It is also developing NX-0479/GS-6791, a IRAK4 degrader for the treatment of rheumatoid arthritis and other inflammatory diseases. The company has a strategic collaboration agreement with Gilead Sciences, Inc. (Gilead), Sanofi S.A. (Sanofi), and Pfizer Inc. (Pfizer) for co-development and co-commercialization for multiple drug candidates. The company was formerly known as Nurix Inc. and changed its name to Nurix Therapeutics, Inc. in October 2018. Nurix Therapeutics, Inc. was incorporated in 2009 and is headquartered in Brisbane, California. more

Industry: BiotechnologySector: Health Care

Nurix Therapeutics Inc Stock Returns

Time Frame	NRIX	Sector	S&P500
1-Week Return	-5.17%	1.51%	-1.5%
1-Month Return	-14.47%	1.46%	0.6%
3-Month Return	21.97%	3.94%	2.43%
6-Month Return	52.87%	16.03%	6.01%
1-Year Return	-6.75%	9.1%	11.48%
3-Year Return	60.49%	19.46%	67.52%
5-Year Return	-60.77%	35.29%	73.75%
10-Year Return	-17.94%	137.42%	254.46%

Time Frame	NRIX	Sector	S&P500
1-Week Return	-93.72%	118.47%	-54.53%
1-Month Return	-85.07%	19.29%	7.55%
3-Month Return	123.77%	16.97%	10.23%
6-Month Return	136.46%	35.19%	12.56%
1-Year Return	-6.75%	9.10%	11.48%
3-Year Return	17.08%	6.11%	18.77%
5-Year Return	-17.07%	6.23%	11.68%
10-Year Return	-1.96%	9.03%	13.49%

Nurix Therapeutics Inc Financials

	Nov '21	Nov '22	Nov '23	Nov '24	Nov '25	5YR TREND
Total Revenue	29.75M	38.63M	76.99M	54.55M	83.98M	[{"date":"2021-11-30","value":35.43,"profit":true},{"date":"2022-11-30","value":46,"profit":true},{"date":"2023-11-30","value":91.67,"profit":true},{"date":"2024-11-30","value":64.95,"profit":true},{"date":"2025-11-30","value":100,"profit":true}]
Cost of Revenue	6.08M	10.81M	189.15M	221.63M	18.86M	[{"date":"2021-11-30","value":2.74,"profit":true},{"date":"2022-11-30","value":4.88,"profit":true},{"date":"2023-11-30","value":85.34,"profit":true},{"date":"2024-11-30","value":100,"profit":true},{"date":"2025-11-30","value":8.51,"profit":true}]
Gross Profit	29.75M	38.63M	(112.16M)	(167.08M)	65.12M	[{"date":"2021-11-30","value":45.68,"profit":true},{"date":"2022-11-30","value":59.31,"profit":true},{"date":"2023-11-30","value":-172.23,"profit":false},{"date":"2024-11-30","value":-256.56,"profit":false},{"date":"2025-11-30","value":100,"profit":true}]
Gross Margin	100.00%	100.00%	(145.69%)	(306.30%)	77.55%	[{"date":"2021-11-30","value":100,"profit":true},{"date":"2022-11-30","value":100,"profit":true},{"date":"2023-11-30","value":-145.69,"profit":false},{"date":"2024-11-30","value":-306.3,"profit":false},{"date":"2025-11-30","value":77.55,"profit":true}]

Operating Expenses	147.64M	222.49M	42.90M	45.94M	350.79M	[{"date":"2021-11-30","value":42.09,"profit":true},{"date":"2022-11-30","value":63.43,"profit":true},{"date":"2023-11-30","value":12.23,"profit":true},{"date":"2024-11-30","value":13.1,"profit":true},{"date":"2025-11-30","value":100,"profit":true}]
Operating Income	(117.89M)	(183.87M)	(155.06M)	(213.03M)	(285.67M)	[{"date":"2021-11-30","value":-11788600000,"profit":false},{"date":"2022-11-30","value":-18386700000,"profit":false},{"date":"2023-11-30","value":-15506300000,"profit":false},{"date":"2024-11-30","value":-21302700000,"profit":false},{"date":"2025-11-30","value":-28566600000,"profit":false}]
Total Non-Operating Income/Expense	1.65M	7.01M	22.23M	39.46M	43.94M	[{"date":"2021-11-30","value":3.75,"profit":true},{"date":"2022-11-30","value":15.96,"profit":true},{"date":"2023-11-30","value":50.59,"profit":true},{"date":"2024-11-30","value":89.8,"profit":true},{"date":"2025-11-30","value":100,"profit":true}]
Pre-Tax Income	(117.06M)	(180.36M)	(143.95M)	(193.30M)	(263.70M)	[{"date":"2021-11-30","value":-11706300000,"profit":false},{"date":"2022-11-30","value":-18036000000,"profit":false},{"date":"2023-11-30","value":-14394800000,"profit":false},{"date":"2024-11-30","value":-19329900000,"profit":false},{"date":"2025-11-30","value":-26369700000,"profit":false}]
Income Taxes	131.00K	(14.31M)	13.49M	270.00K	760.00K	[{"date":"2021-11-30","value":0.97,"profit":true},{"date":"2022-11-30","value":-106.15,"profit":false},{"date":"2023-11-30","value":100,"profit":true},{"date":"2024-11-30","value":2,"profit":true},{"date":"2025-11-30","value":5.64,"profit":true}]
Income After Taxes	(117.19M)	(166.04M)	(157.43M)	(193.57M)	(264.46M)	[{"date":"2021-11-30","value":-11719400000,"profit":false},{"date":"2022-11-30","value":-16604500000,"profit":false},{"date":"2023-11-30","value":-15743410500,"profit":false},{"date":"2024-11-30","value":-19356900000,"profit":false},{"date":"2025-11-30","value":-26445700000,"profit":false}]

Income From Continuous Operations	(117.19M)	(180.36M)	(143.95M)	(193.57M)	(264.46M)	[{"date":"2021-11-30","value":-11719400000,"profit":false},{"date":"2022-11-30","value":-18036000000,"profit":false},{"date":"2023-11-30","value":-14394800000,"profit":false},{"date":"2024-11-30","value":-19356900000,"profit":false},{"date":"2025-11-30","value":-26445700000,"profit":false}]
Income From Discontinued Operations	-	-	-	-	-	[{"date":"2021-11-30","value":"-","profit":true},{"date":"2022-11-30","value":"-","profit":true},{"date":"2023-11-30","value":"-","profit":true},{"date":"2024-11-30","value":"-","profit":true},{"date":"2025-11-30","value":"-","profit":true}]
Net Income	(117.19M)	(166.04M)	(143.95M)	(193.57M)	(264.46M)	[{"date":"2021-11-30","value":-11719400000,"profit":false},{"date":"2022-11-30","value":-16604500000,"profit":false},{"date":"2023-11-30","value":-14394800000,"profit":false},{"date":"2024-11-30","value":-19356900000,"profit":false},{"date":"2025-11-30","value":-26445700000,"profit":false}]

EPS (Diluted)	(2.73)	(3.73)	(2.65)	(2.89)	(3.04)	[{"date":"2021-11-30","value":-273,"profit":false},{"date":"2022-11-30","value":-373,"profit":false},{"date":"2023-11-30","value":-265,"profit":false},{"date":"2024-11-30","value":-289,"profit":false},{"date":"2025-11-30","value":-304,"profit":false}]

	Nov '21	Nov '22	Nov '23	Nov '24	Nov '25	5YR TREND
Total Revenue	-	29.84%	99.31%	(29.15%)	53.95%	[{"date":"2021-11-30","value":"-","profit":true},{"date":"2022-11-30","value":30.05,"profit":true},{"date":"2023-11-30","value":100,"profit":true},{"date":"2024-11-30","value":-29.35,"profit":false},{"date":"2025-11-30","value":54.33,"profit":true}]
Cost of Revenue	-	77.70%	1650.07%	17.17%	(91.49%)	[{"date":"2021-11-30","value":"-","profit":true},{"date":"2022-11-30","value":4.71,"profit":true},{"date":"2023-11-30","value":100,"profit":true},{"date":"2024-11-30","value":1.04,"profit":true},{"date":"2025-11-30","value":-5.54,"profit":false}]
Gross Profit	-	29.84%	(390.37%)	48.97%	(138.98%)	[{"date":"2021-11-30","value":"-","profit":true},{"date":"2022-11-30","value":60.94,"profit":true},{"date":"2023-11-30","value":-797.21,"profit":false},{"date":"2024-11-30","value":100,"profit":true},{"date":"2025-11-30","value":-283.82,"profit":false}]
Gross Margin	-	-	(245.69%)	110.24%	(125.32%)	[{"date":"2021-11-30","value":"-","profit":true},{"date":"2022-11-30","value":"-","profit":true},{"date":"2023-11-30","value":-222.86,"profit":false},{"date":"2024-11-30","value":100,"profit":true},{"date":"2025-11-30","value":-113.67,"profit":false}]

Operating Expenses	-	50.70%	(80.72%)	7.09%	663.52%	[{"date":"2021-11-30","value":"-","profit":true},{"date":"2022-11-30","value":7.64,"profit":true},{"date":"2023-11-30","value":-12.17,"profit":false},{"date":"2024-11-30","value":1.07,"profit":true},{"date":"2025-11-30","value":100,"profit":true}]
Operating Income	-	55.97%	(15.67%)	37.38%	34.10%	[{"date":"2021-11-30","value":"-","profit":true},{"date":"2022-11-30","value":100,"profit":true},{"date":"2023-11-30","value":-27.99,"profit":false},{"date":"2024-11-30","value":66.79,"profit":true},{"date":"2025-11-30","value":60.92,"profit":true}]
Total Non-Operating Income/Expense	-	326.12%	216.94%	77.49%	11.36%	[{"date":"2021-11-30","value":"-","profit":true},{"date":"2022-11-30","value":100,"profit":true},{"date":"2023-11-30","value":66.52,"profit":true},{"date":"2024-11-30","value":23.76,"profit":true},{"date":"2025-11-30","value":3.48,"profit":true}]
Pre-Tax Income	-	54.07%	(20.19%)	34.28%	36.42%	[{"date":"2021-11-30","value":"-","profit":true},{"date":"2022-11-30","value":100,"profit":true},{"date":"2023-11-30","value":-37.34,"profit":false},{"date":"2024-11-30","value":63.41,"profit":true},{"date":"2025-11-30","value":67.35,"profit":true}]
Income Taxes	-	(11027.48%)	(194.21%)	(98.00%)	181.48%	[{"date":"2021-11-30","value":"-","profit":true},{"date":"2022-11-30","value":-6076.37,"profit":false},{"date":"2023-11-30","value":-107.01,"profit":false},{"date":"2024-11-30","value":-54,"profit":false},{"date":"2025-11-30","value":100,"profit":true}]
Income After Taxes	-	41.68%	(5.19%)	22.95%	36.62%	[{"date":"2021-11-30","value":"-","profit":true},{"date":"2022-11-30","value":100,"profit":true},{"date":"2023-11-30","value":-12.44,"profit":false},{"date":"2024-11-30","value":55.06,"profit":true},{"date":"2025-11-30","value":87.86,"profit":true}]

Income From Continuous Operations	-	53.90%	(20.19%)	34.47%	36.62%	[{"date":"2021-11-30","value":"-","profit":true},{"date":"2022-11-30","value":100,"profit":true},{"date":"2023-11-30","value":-37.46,"profit":false},{"date":"2024-11-30","value":63.96,"profit":true},{"date":"2025-11-30","value":67.95,"profit":true}]
Income From Discontinued Operations	-	-	-	-	-	[{"date":"2021-11-30","value":"-","profit":true},{"date":"2022-11-30","value":"-","profit":true},{"date":"2023-11-30","value":"-","profit":true},{"date":"2024-11-30","value":"-","profit":true},{"date":"2025-11-30","value":"-","profit":true}]
Net Income	-	41.68%	(13.31%)	34.47%	36.62%	[{"date":"2021-11-30","value":"-","profit":true},{"date":"2022-11-30","value":100,"profit":true},{"date":"2023-11-30","value":-31.93,"profit":false},{"date":"2024-11-30","value":82.7,"profit":true},{"date":"2025-11-30","value":87.86,"profit":true}]

EPS (Diluted)	-	36.63%	(28.95%)	9.06%	5.19%	[{"date":"2021-11-30","value":"-","profit":true},{"date":"2022-11-30","value":100,"profit":true},{"date":"2023-11-30","value":-79.05,"profit":false},{"date":"2024-11-30","value":24.72,"profit":true},{"date":"2025-11-30","value":14.17,"profit":true}]

	Nov '24	Feb '25	May '25	Aug '25	Nov '25	TREND
Total Revenue	13.28M	18.45M	44.06M	7.89M	13.58M	[{"date":"2024-11-30","value":30.15,"profit":true},{"date":"2025-02-28","value":41.89,"profit":true},{"date":"2025-05-31","value":100,"profit":true},{"date":"2025-08-31","value":17.92,"profit":true},{"date":"2025-11-30","value":30.82,"profit":true}]
Cost of Revenue	67.22M	69.66M	78.10M	5.00M	4.63M	[{"date":"2024-11-30","value":86.08,"profit":true},{"date":"2025-02-28","value":89.2,"profit":true},{"date":"2025-05-31","value":100,"profit":true},{"date":"2025-08-31","value":6.4,"profit":true},{"date":"2025-11-30","value":5.93,"profit":true}]
Gross Profit	(53.94M)	(51.21M)	(34.04M)	2.89M	8.95M	[{"date":"2024-11-30","value":-602.95,"profit":false},{"date":"2025-02-28","value":-572.43,"profit":false},{"date":"2025-05-31","value":-380.51,"profit":false},{"date":"2025-08-31","value":32.35,"profit":true},{"date":"2025-11-30","value":100,"profit":true}]
Gross Margin	(406.05%)	(277.52%)	(77.27%)	36.66%	65.89%	[{"date":"2024-11-30","value":-616.25,"profit":false},{"date":"2025-02-28","value":-421.18,"profit":false},{"date":"2025-05-31","value":-117.26,"profit":false},{"date":"2025-08-31","value":55.64,"profit":true},{"date":"2025-11-30","value":100,"profit":true}]

Operating Expenses	10.72M	11.65M	14.28M	94.28M	92.04M	[{"date":"2024-11-30","value":11.37,"profit":true},{"date":"2025-02-28","value":12.36,"profit":true},{"date":"2025-05-31","value":15.15,"profit":true},{"date":"2025-08-31","value":100,"profit":true},{"date":"2025-11-30","value":97.63,"profit":true}]
Operating Income	(64.66M)	(62.86M)	(48.32M)	(91.39M)	(83.09M)	[{"date":"2024-11-30","value":-6465700000,"profit":false},{"date":"2025-02-28","value":-6286400000,"profit":false},{"date":"2025-05-31","value":-4832200000,"profit":false},{"date":"2025-08-31","value":-9138500000,"profit":false},{"date":"2025-11-30","value":-8309500000,"profit":false}]
Total Non-Operating Income/Expense	12.23M	13.03M	11.24M	9.93M	9.75M	[{"date":"2024-11-30","value":93.9,"profit":true},{"date":"2025-02-28","value":100,"profit":true},{"date":"2025-05-31","value":86.26,"profit":true},{"date":"2025-08-31","value":76.22,"profit":true},{"date":"2025-11-30","value":74.83,"profit":true}]
Pre-Tax Income	(58.54M)	(56.35M)	(42.70M)	(86.42M)	(78.22M)	[{"date":"2024-11-30","value":-5854100000,"profit":false},{"date":"2025-02-28","value":-5635100000,"profit":false},{"date":"2025-05-31","value":-4270400000,"profit":false},{"date":"2025-08-31","value":-8642100000,"profit":false},{"date":"2025-11-30","value":-7822100000,"profit":false}]
Income Taxes	8.00K	-	760.00K	-	-	[{"date":"2024-11-30","value":1.05,"profit":true},{"date":"2025-02-28","value":"-","profit":true},{"date":"2025-05-31","value":100,"profit":true},{"date":"2025-08-31","value":"-","profit":true},{"date":"2025-11-30","value":"-","profit":true}]
Income After Taxes	(58.55M)	-	(43.46M)	-	-	[{"date":"2024-11-30","value":-5854900000,"profit":false},{"date":"2025-02-28","value":"-","profit":true},{"date":"2025-05-31","value":-4346400000,"profit":false},{"date":"2025-08-31","value":"-","profit":true},{"date":"2025-11-30","value":"-","profit":true}]

Income From Continuous Operations	(58.55M)	(56.35M)	(43.46M)	(86.42M)	(78.22M)	[{"date":"2024-11-30","value":-5854900000,"profit":false},{"date":"2025-02-28","value":-5635100000,"profit":false},{"date":"2025-05-31","value":-4346400000,"profit":false},{"date":"2025-08-31","value":-8642100000,"profit":false},{"date":"2025-11-30","value":-7822100000,"profit":false}]
Income From Discontinued Operations	-	-	-	-	-	[{"date":"2024-11-30","value":"-","profit":true},{"date":"2025-02-28","value":"-","profit":true},{"date":"2025-05-31","value":"-","profit":true},{"date":"2025-08-31","value":"-","profit":true},{"date":"2025-11-30","value":"-","profit":true}]
Net Income	(58.55M)	(56.35M)	(43.46M)	(86.42M)	(78.22M)	[{"date":"2024-11-30","value":-5854900000,"profit":false},{"date":"2025-02-28","value":-5635100000,"profit":false},{"date":"2025-05-31","value":-4346400000,"profit":false},{"date":"2025-08-31","value":-8642100000,"profit":false},{"date":"2025-11-30","value":-7822100000,"profit":false}]

EPS (Diluted)	(0.75)	(0.67)	(0.52)	(1.03)	(0.82)	[{"date":"2024-11-30","value":-75,"profit":false},{"date":"2025-02-28","value":-67,"profit":false},{"date":"2025-05-31","value":-52,"profit":false},{"date":"2025-08-31","value":-103,"profit":false},{"date":"2025-11-30","value":-82,"profit":false}]

	Nov '24	Feb '25	May '25	Aug '25	Nov '25	TREND
Total Revenue	-	38.91%	138.75%	(82.08%)	71.99%	[{"date":"2024-11-30","value":"-","profit":true},{"date":"2025-02-28","value":28.04,"profit":true},{"date":"2025-05-31","value":100,"profit":true},{"date":"2025-08-31","value":-59.16,"profit":false},{"date":"2025-11-30","value":51.89,"profit":true}]
Cost of Revenue	-	3.63%	12.11%	(93.60%)	(7.38%)	[{"date":"2024-11-30","value":"-","profit":true},{"date":"2025-02-28","value":29.97,"profit":true},{"date":"2025-05-31","value":100,"profit":true},{"date":"2025-08-31","value":-773.19,"profit":false},{"date":"2025-11-30","value":-60.96,"profit":false}]
Gross Profit	-	(5.06%)	(33.53%)	(108.50%)	209.12%	[{"date":"2024-11-30","value":"-","profit":true},{"date":"2025-02-28","value":-2.42,"profit":false},{"date":"2025-05-31","value":-16.03,"profit":false},{"date":"2025-08-31","value":-51.88,"profit":false},{"date":"2025-11-30","value":100,"profit":true}]
Gross Margin	-	(31.66%)	(72.16%)	(147.45%)	79.73%	[{"date":"2024-11-30","value":"-","profit":true},{"date":"2025-02-28","value":-39.7,"profit":false},{"date":"2025-05-31","value":-90.5,"profit":false},{"date":"2025-08-31","value":-184.93,"profit":false},{"date":"2025-11-30","value":100,"profit":true}]

Operating Expenses	-	8.74%	22.55%	560.12%	(2.37%)	[{"date":"2024-11-30","value":"-","profit":true},{"date":"2025-02-28","value":1.56,"profit":true},{"date":"2025-05-31","value":4.03,"profit":true},{"date":"2025-08-31","value":100,"profit":true},{"date":"2025-11-30","value":-0.42,"profit":false}]
Operating Income	-	(2.77%)	(23.13%)	89.12%	(9.07%)	[{"date":"2024-11-30","value":"-","profit":true},{"date":"2025-02-28","value":-3.11,"profit":false},{"date":"2025-05-31","value":-25.96,"profit":false},{"date":"2025-08-31","value":100,"profit":true},{"date":"2025-11-30","value":-10.18,"profit":false}]
Total Non-Operating Income/Expense	-	6.49%	(13.74%)	(11.64%)	(1.81%)	[{"date":"2024-11-30","value":"-","profit":true},{"date":"2025-02-28","value":100,"profit":true},{"date":"2025-05-31","value":-211.7,"profit":false},{"date":"2025-08-31","value":-179.34,"profit":false},{"date":"2025-11-30","value":-27.93,"profit":false}]
Pre-Tax Income	-	(3.74%)	(24.22%)	102.37%	(9.49%)	[{"date":"2024-11-30","value":"-","profit":true},{"date":"2025-02-28","value":-3.65,"profit":false},{"date":"2025-05-31","value":-23.66,"profit":false},{"date":"2025-08-31","value":100,"profit":true},{"date":"2025-11-30","value":-9.27,"profit":false}]
Income Taxes	-	-	-	-	-	[{"date":"2024-11-30","value":"-","profit":true},{"date":"2025-02-28","value":"-","profit":true},{"date":"2025-05-31","value":"-","profit":true},{"date":"2025-08-31","value":"-","profit":true},{"date":"2025-11-30","value":"-","profit":true}]
Income After Taxes	-	-	-	-	-	[{"date":"2024-11-30","value":"-","profit":true},{"date":"2025-02-28","value":"-","profit":true},{"date":"2025-05-31","value":"-","profit":true},{"date":"2025-08-31","value":"-","profit":true},{"date":"2025-11-30","value":"-","profit":true}]

Income From Continuous Operations	-	(3.75%)	(22.87%)	98.83%	(9.49%)	[{"date":"2024-11-30","value":"-","profit":true},{"date":"2025-02-28","value":-3.8,"profit":false},{"date":"2025-05-31","value":-23.14,"profit":false},{"date":"2025-08-31","value":100,"profit":true},{"date":"2025-11-30","value":-9.6,"profit":false}]
Income From Discontinued Operations	-	-	-	-	-	[{"date":"2024-11-30","value":"-","profit":true},{"date":"2025-02-28","value":"-","profit":true},{"date":"2025-05-31","value":"-","profit":true},{"date":"2025-08-31","value":"-","profit":true},{"date":"2025-11-30","value":"-","profit":true}]
Net Income	-	(3.75%)	(22.87%)	98.83%	(9.49%)	[{"date":"2024-11-30","value":"-","profit":true},{"date":"2025-02-28","value":-3.8,"profit":false},{"date":"2025-05-31","value":-23.14,"profit":false},{"date":"2025-08-31","value":100,"profit":true},{"date":"2025-11-30","value":-9.6,"profit":false}]

EPS (Diluted)	-	(10.67%)	(22.39%)	98.08%	(20.39%)	[{"date":"2024-11-30","value":"-","profit":true},{"date":"2025-02-28","value":-10.88,"profit":false},{"date":"2025-05-31","value":-22.83,"profit":false},{"date":"2025-08-31","value":100,"profit":true},{"date":"2025-11-30","value":-20.79,"profit":false}]

	Nov '21	Nov '22	Nov '23	Nov '24	Nov '25	5YR TREND
Total Assets
Current Assets	311.12M	318.45M	295.50M	619.39M	606.82M	[{"date":"2021-11-30","value":50.23,"profit":true},{"date":"2022-11-30","value":51.41,"profit":true},{"date":"2023-11-30","value":47.71,"profit":true},{"date":"2024-11-30","value":100,"profit":true},{"date":"2025-11-30","value":97.97,"profit":true}]
Non-current Assets	165.65M	98.31M	60.09M	49.96M	81.32M	[{"date":"2021-11-30","value":100,"profit":true},{"date":"2022-11-30","value":59.35,"profit":true},{"date":"2023-11-30","value":36.28,"profit":true},{"date":"2024-11-30","value":30.16,"profit":true},{"date":"2025-11-30","value":49.09,"profit":true}]
Total Assets	476.77M	416.76M	355.60M	669.34M	688.13M	[{"date":"2021-11-30","value":69.28,"profit":true},{"date":"2022-11-30","value":60.56,"profit":true},{"date":"2023-11-30","value":51.68,"profit":true},{"date":"2024-11-30","value":97.27,"profit":true},{"date":"2025-11-30","value":100,"profit":true}]

Total Liabilities
Current Liabilities	66.26M	70.66M	86.96M	95.85M	86.47M	[{"date":"2021-11-30","value":69.12,"profit":true},{"date":"2022-11-30","value":73.71,"profit":true},{"date":"2023-11-30","value":90.72,"profit":true},{"date":"2024-11-30","value":100,"profit":true},{"date":"2025-11-30","value":90.21,"profit":true}]
Non-current Liabilities	68.21M	42.41M	68.15M	46.50M	62.92M	[{"date":"2021-11-30","value":100,"profit":true},{"date":"2022-11-30","value":62.17,"profit":true},{"date":"2023-11-30","value":99.91,"profit":true},{"date":"2024-11-30","value":68.16,"profit":true},{"date":"2025-11-30","value":92.24,"profit":true}]
Total Liabilities	134.47M	113.06M	155.10M	142.35M	149.39M	[{"date":"2021-11-30","value":86.7,"profit":true},{"date":"2022-11-30","value":72.89,"profit":true},{"date":"2023-11-30","value":100,"profit":true},{"date":"2024-11-30","value":91.78,"profit":true},{"date":"2025-11-30","value":96.31,"profit":true}]

Total Shareholders' equity
Common Stock	45.00K	47.00K	49.00K	76.00K	102.00K	[{"date":"2021-11-30","value":44.12,"profit":true},{"date":"2022-11-30","value":46.08,"profit":true},{"date":"2023-11-30","value":48.04,"profit":true},{"date":"2024-11-30","value":74.51,"profit":true},{"date":"2025-11-30","value":100,"profit":true}]
Retained Earnings	(220.89M)	(401.25M)	(545.20M)	(738.77M)	(1.00B)	[{"date":"2021-11-30","value":-22089200000,"profit":false},{"date":"2022-11-30","value":-40125200000,"profit":false},{"date":"2023-11-30","value":-54520000000,"profit":false},{"date":"2024-11-30","value":-73876900000,"profit":false},{"date":"2025-11-30","value":-100322600000,"profit":false}]
Other Stockholders' Equity	563.76M	709.22M	746.30M	1.27B	1.54B	[{"date":"2021-11-30","value":36.57,"profit":true},{"date":"2022-11-30","value":46,"profit":true},{"date":"2023-11-30","value":48.41,"profit":true},{"date":"2024-11-30","value":82.08,"profit":true},{"date":"2025-11-30","value":100,"profit":true}]
Total Shareholders' equity	342.30M	303.70M	200.49M	526.99M	538.75M	[{"date":"2021-11-30","value":63.54,"profit":true},{"date":"2022-11-30","value":56.37,"profit":true},{"date":"2023-11-30","value":37.21,"profit":true},{"date":"2024-11-30","value":97.82,"profit":true},{"date":"2025-11-30","value":100,"profit":true}]

Total Liabilities & Shareholders Equity	476.77M	416.76M	355.60M	669.34M	688.13M	[{"date":"2021-11-30","value":69.28,"profit":true},{"date":"2022-11-30","value":60.56,"profit":true},{"date":"2023-11-30","value":51.68,"profit":true},{"date":"2024-11-30","value":97.27,"profit":true},{"date":"2025-11-30","value":100,"profit":true}]

	Nov '21	Nov '22	Nov '23	Nov '24	Nov '25	5YR TREND
Total Assets
Current Assets	-	2.36%	(7.21%)	109.60%	(2.03%)	[{"date":"2021-11-30","value":"-","profit":true},{"date":"2022-11-30","value":2.15,"profit":true},{"date":"2023-11-30","value":-6.57,"profit":false},{"date":"2024-11-30","value":100,"profit":true},{"date":"2025-11-30","value":-1.85,"profit":false}]
Non-current Assets	-	(40.65%)	(38.87%)	(16.87%)	62.78%	[{"date":"2021-11-30","value":"-","profit":true},{"date":"2022-11-30","value":-64.76,"profit":false},{"date":"2023-11-30","value":-61.92,"profit":false},{"date":"2024-11-30","value":-26.88,"profit":false},{"date":"2025-11-30","value":100,"profit":true}]
Total Assets	-	(12.59%)	(14.68%)	88.23%	2.81%	[{"date":"2021-11-30","value":"-","profit":true},{"date":"2022-11-30","value":-14.27,"profit":false},{"date":"2023-11-30","value":-16.63,"profit":false},{"date":"2024-11-30","value":100,"profit":true},{"date":"2025-11-30","value":3.18,"profit":true}]

Total Liabilities
Current Liabilities	-	6.64%	23.07%	10.23%	(9.79%)	[{"date":"2021-11-30","value":"-","profit":true},{"date":"2022-11-30","value":28.76,"profit":true},{"date":"2023-11-30","value":100,"profit":true},{"date":"2024-11-30","value":44.34,"profit":true},{"date":"2025-11-30","value":-42.42,"profit":false}]
Non-current Liabilities	-	(37.83%)	60.69%	(31.77%)	35.32%	[{"date":"2021-11-30","value":"-","profit":true},{"date":"2022-11-30","value":-62.33,"profit":false},{"date":"2023-11-30","value":100,"profit":true},{"date":"2024-11-30","value":-52.35,"profit":false},{"date":"2025-11-30","value":58.19,"profit":true}]
Total Liabilities	-	(15.92%)	37.18%	(8.22%)	4.94%	[{"date":"2021-11-30","value":"-","profit":true},{"date":"2022-11-30","value":-42.81,"profit":false},{"date":"2023-11-30","value":100,"profit":true},{"date":"2024-11-30","value":-22.12,"profit":false},{"date":"2025-11-30","value":13.3,"profit":true}]

Total Shareholders' equity
Common Stock	-	4.44%	4.26%	55.10%	34.21%	[{"date":"2021-11-30","value":"-","profit":true},{"date":"2022-11-30","value":8.07,"profit":true},{"date":"2023-11-30","value":7.72,"profit":true},{"date":"2024-11-30","value":100,"profit":true},{"date":"2025-11-30","value":62.09,"profit":true}]
Retained Earnings	-	81.65%	35.87%	35.50%	35.80%	[{"date":"2021-11-30","value":"-","profit":true},{"date":"2022-11-30","value":100,"profit":true},{"date":"2023-11-30","value":43.94,"profit":true},{"date":"2024-11-30","value":43.48,"profit":true},{"date":"2025-11-30","value":43.84,"profit":true}]
Other Stockholders' Equity	-	25.80%	5.23%	69.57%	21.83%	[{"date":"2021-11-30","value":"-","profit":true},{"date":"2022-11-30","value":37.09,"profit":true},{"date":"2023-11-30","value":7.51,"profit":true},{"date":"2024-11-30","value":100,"profit":true},{"date":"2025-11-30","value":31.37,"profit":true}]
Total Shareholders' equity	-	(11.28%)	(33.98%)	162.85%	2.23%	[{"date":"2021-11-30","value":"-","profit":true},{"date":"2022-11-30","value":-6.93,"profit":false},{"date":"2023-11-30","value":-20.87,"profit":false},{"date":"2024-11-30","value":100,"profit":true},{"date":"2025-11-30","value":1.37,"profit":true}]

Total Liabilities & Shareholders Equity	-	(12.59%)	(14.68%)	88.23%	2.81%	[{"date":"2021-11-30","value":"-","profit":true},{"date":"2022-11-30","value":-14.27,"profit":false},{"date":"2023-11-30","value":-16.63,"profit":false},{"date":"2024-11-30","value":100,"profit":true},{"date":"2025-11-30","value":3.18,"profit":true}]

	Nov '24	Feb '25	May '25	Aug '25	Nov '25	TREND
Total Assets
Current Assets	619.39M	563.70M	515.33M	440.60M	606.82M	[{"date":"2024-11-30","value":100,"profit":true},{"date":"2025-02-28","value":91.01,"profit":true},{"date":"2025-05-31","value":83.2,"profit":true},{"date":"2025-08-31","value":71.14,"profit":true},{"date":"2025-11-30","value":97.97,"profit":true}]
Non-current Assets	49.96M	51.34M	76.22M	81.87M	81.32M	[{"date":"2024-11-30","value":61.02,"profit":true},{"date":"2025-02-28","value":62.71,"profit":true},{"date":"2025-05-31","value":93.11,"profit":true},{"date":"2025-08-31","value":100,"profit":true},{"date":"2025-11-30","value":99.32,"profit":true}]
Total Assets	669.34M	615.04M	591.55M	522.47M	688.13M	[{"date":"2024-11-30","value":97.27,"profit":true},{"date":"2025-02-28","value":89.38,"profit":true},{"date":"2025-05-31","value":85.96,"profit":true},{"date":"2025-08-31","value":75.93,"profit":true},{"date":"2025-11-30","value":100,"profit":true}]

Total Liabilities
Current Liabilities	95.85M	89.99M	75.61M	82.35M	86.47M	[{"date":"2024-11-30","value":100,"profit":true},{"date":"2025-02-28","value":93.88,"profit":true},{"date":"2025-05-31","value":78.88,"profit":true},{"date":"2025-08-31","value":85.91,"profit":true},{"date":"2025-11-30","value":90.21,"profit":true}]
Non-current Liabilities	46.50M	44.14M	68.34M	67.87M	62.92M	[{"date":"2024-11-30","value":68.04,"profit":true},{"date":"2025-02-28","value":64.59,"profit":true},{"date":"2025-05-31","value":100,"profit":true},{"date":"2025-08-31","value":99.32,"profit":true},{"date":"2025-11-30","value":92.07,"profit":true}]
Total Liabilities	142.35M	134.13M	143.95M	150.22M	149.39M	[{"date":"2024-11-30","value":94.76,"profit":true},{"date":"2025-02-28","value":89.29,"profit":true},{"date":"2025-05-31","value":95.83,"profit":true},{"date":"2025-08-31","value":100,"profit":true},{"date":"2025-11-30","value":99.45,"profit":true}]

Total Shareholders' equity
Common Stock	76.00K	76.00K	76.00K	77.00K	102.00K	[{"date":"2024-11-30","value":74.51,"profit":true},{"date":"2025-02-28","value":74.51,"profit":true},{"date":"2025-05-31","value":74.51,"profit":true},{"date":"2025-08-31","value":75.49,"profit":true},{"date":"2025-11-30","value":100,"profit":true}]
Retained Earnings	(738.77M)	(795.12M)	(838.58M)	(925.00M)	(1.00B)	[{"date":"2024-11-30","value":-73876900000,"profit":false},{"date":"2025-02-28","value":-79512000000,"profit":false},{"date":"2025-05-31","value":-83858400000,"profit":false},{"date":"2025-08-31","value":-92500500000,"profit":false},{"date":"2025-11-30","value":-100322600000,"profit":false}]
Other Stockholders' Equity	1.27B	1.28B	1.29B	1.30B	1.54B	[{"date":"2024-11-30","value":82.08,"profit":true},{"date":"2025-02-28","value":82.75,"profit":true},{"date":"2025-05-31","value":83.42,"profit":true},{"date":"2025-08-31","value":84.13,"profit":true},{"date":"2025-11-30","value":100,"profit":true}]
Total Shareholders' equity	526.99M	480.92M	447.60M	372.25M	538.75M	[{"date":"2024-11-30","value":97.82,"profit":true},{"date":"2025-02-28","value":89.27,"profit":true},{"date":"2025-05-31","value":83.08,"profit":true},{"date":"2025-08-31","value":69.1,"profit":true},{"date":"2025-11-30","value":100,"profit":true}]

Total Liabilities & Shareholders Equity	669.34M	615.04M	591.55M	522.47M	688.13M	[{"date":"2024-11-30","value":97.27,"profit":true},{"date":"2025-02-28","value":89.38,"profit":true},{"date":"2025-05-31","value":85.96,"profit":true},{"date":"2025-08-31","value":75.93,"profit":true},{"date":"2025-11-30","value":100,"profit":true}]

	Nov '24	Feb '25	May '25	Aug '25	Nov '25	TREND
Total Assets
Current Assets	-	(8.99%)	(8.58%)	(14.50%)	37.72%	[{"date":"2024-11-30","value":"-","profit":true},{"date":"2025-02-28","value":-23.83,"profit":false},{"date":"2025-05-31","value":-22.75,"profit":false},{"date":"2025-08-31","value":-38.44,"profit":false},{"date":"2025-11-30","value":100,"profit":true}]
Non-current Assets	-	2.77%	48.47%	7.40%	(0.68%)	[{"date":"2024-11-30","value":"-","profit":true},{"date":"2025-02-28","value":5.72,"profit":true},{"date":"2025-05-31","value":100,"profit":true},{"date":"2025-08-31","value":15.28,"profit":true},{"date":"2025-11-30","value":-1.39,"profit":false}]
Total Assets	-	(8.11%)	(3.82%)	(11.68%)	31.71%	[{"date":"2024-11-30","value":"-","profit":true},{"date":"2025-02-28","value":-25.59,"profit":false},{"date":"2025-05-31","value":-12.04,"profit":false},{"date":"2025-08-31","value":-36.83,"profit":false},{"date":"2025-11-30","value":100,"profit":true}]

Total Liabilities
Current Liabilities	-	(6.12%)	(15.97%)	8.91%	5.00%	[{"date":"2024-11-30","value":"-","profit":true},{"date":"2025-02-28","value":-68.7,"profit":false},{"date":"2025-05-31","value":-179.31,"profit":false},{"date":"2025-08-31","value":100,"profit":true},{"date":"2025-11-30","value":56.17,"profit":true}]
Non-current Liabilities	-	(5.07%)	54.83%	(0.68%)	(7.30%)	[{"date":"2024-11-30","value":"-","profit":true},{"date":"2025-02-28","value":-9.25,"profit":false},{"date":"2025-05-31","value":100,"profit":true},{"date":"2025-08-31","value":-1.25,"profit":false},{"date":"2025-11-30","value":-13.31,"profit":false}]
Total Liabilities	-	(5.78%)	7.33%	4.35%	(0.55%)	[{"date":"2024-11-30","value":"-","profit":true},{"date":"2025-02-28","value":-78.86,"profit":false},{"date":"2025-05-31","value":100,"profit":true},{"date":"2025-08-31","value":59.44,"profit":true},{"date":"2025-11-30","value":-7.56,"profit":false}]

Total Shareholders' equity
Common Stock	-	-	-	1.32%	32.47%	[{"date":"2024-11-30","value":"-","profit":true},{"date":"2025-02-28","value":"-","profit":true},{"date":"2025-05-31","value":"-","profit":true},{"date":"2025-08-31","value":4.05,"profit":true},{"date":"2025-11-30","value":100,"profit":true}]
Retained Earnings	-	7.63%	5.47%	10.31%	8.46%	[{"date":"2024-11-30","value":"-","profit":true},{"date":"2025-02-28","value":74.02,"profit":true},{"date":"2025-05-31","value":53.04,"profit":true},{"date":"2025-08-31","value":100,"profit":true},{"date":"2025-11-30","value":82.06,"profit":true}]
Other Stockholders' Equity	-	0.81%	0.81%	0.85%	18.87%	[{"date":"2024-11-30","value":"-","profit":true},{"date":"2025-02-28","value":4.27,"profit":true},{"date":"2025-05-31","value":4.32,"profit":true},{"date":"2025-08-31","value":4.5,"profit":true},{"date":"2025-11-30","value":100,"profit":true}]
Total Shareholders' equity	-	(8.74%)	(6.93%)	(16.83%)	44.73%	[{"date":"2024-11-30","value":"-","profit":true},{"date":"2025-02-28","value":-19.55,"profit":false},{"date":"2025-05-31","value":-15.49,"profit":false},{"date":"2025-08-31","value":-37.64,"profit":false},{"date":"2025-11-30","value":100,"profit":true}]

Total Liabilities & Shareholders Equity	-	(8.11%)	(3.82%)	(11.68%)	31.71%	[{"date":"2024-11-30","value":"-","profit":true},{"date":"2025-02-28","value":-25.59,"profit":false},{"date":"2025-05-31","value":-12.04,"profit":false},{"date":"2025-08-31","value":-36.83,"profit":false},{"date":"2025-11-30","value":100,"profit":true}]

	Nov '21	Nov '22	Nov '23	Nov '24	Nov '25	5YR TREND
Operating Activities
Net Operating Cash Flow	(84.36M)	(159.81M)	(81.36M)	(172.58M)	(249.47M)	[{"date":"2021-11-30","value":-8436500000,"profit":false},{"date":"2022-11-30","value":-15980700000,"profit":false},{"date":"2023-11-30","value":-8136500000,"profit":false},{"date":"2024-11-30","value":-17258400000,"profit":false},{"date":"2025-11-30","value":-24946500000,"profit":false}]

Investing Activities
Net Investing Cash Flow	(108.25M)	27.20M	68.30M	(257.71M)	147.85M	[{"date":"2021-11-30","value":-73.22,"profit":false},{"date":"2022-11-30","value":18.4,"profit":true},{"date":"2023-11-30","value":46.2,"profit":true},{"date":"2024-11-30","value":-174.3,"profit":false},{"date":"2025-11-30","value":100,"profit":true}]

Financing Activities
Net Financing Cash Flow	153.88M	117.19M	3.22M	485.67M	238.64M	[{"date":"2021-11-30","value":31.68,"profit":true},{"date":"2022-11-30","value":24.13,"profit":true},{"date":"2023-11-30","value":0.66,"profit":true},{"date":"2024-11-30","value":100,"profit":true},{"date":"2025-11-30","value":49.14,"profit":true}]

Net Change in Cash	(38.73M)	(15.42M)	(9.85M)	55.37M	137.03M	[{"date":"2021-11-30","value":-28.27,"profit":false},{"date":"2022-11-30","value":-11.25,"profit":false},{"date":"2023-11-30","value":-7.19,"profit":false},{"date":"2024-11-30","value":40.41,"profit":true},{"date":"2025-11-30","value":100,"profit":true}]

Free Cash Flow
Free Cash Flow	(90.03M)	(172.05M)	(89.77M)	(181.86M)	(263.47M)	[{"date":"2021-11-30","value":-9002600000,"profit":false},{"date":"2022-11-30","value":-17205100000,"profit":false},{"date":"2023-11-30","value":-8976600000,"profit":false},{"date":"2024-11-30","value":-18185700000,"profit":false},{"date":"2025-11-30","value":-26346700000,"profit":false}]

	Nov '21	Nov '22	Nov '23	Nov '24	Nov '25	5YR TREND
Operating Activities
Net Operating Cash Flow	-	89.42%	(49.09%)	112.11%	44.55%	[{"date":"2021-11-30","value":"-","profit":true},{"date":"2022-11-30","value":79.76,"profit":true},{"date":"2023-11-30","value":-43.78,"profit":false},{"date":"2024-11-30","value":100,"profit":true},{"date":"2025-11-30","value":39.73,"profit":true}]

Investing Activities
Net Investing Cash Flow	-	(125.12%)	151.13%	(477.32%)	(157.37%)	[{"date":"2021-11-30","value":"-","profit":true},{"date":"2022-11-30","value":-82.8,"profit":false},{"date":"2023-11-30","value":100,"profit":true},{"date":"2024-11-30","value":-315.84,"profit":false},{"date":"2025-11-30","value":-104.13,"profit":false}]

Financing Activities
Net Financing Cash Flow	-	(23.84%)	(97.25%)	14996.89%	(50.86%)	[{"date":"2021-11-30","value":"-","profit":true},{"date":"2022-11-30","value":-0.16,"profit":false},{"date":"2023-11-30","value":-0.65,"profit":false},{"date":"2024-11-30","value":100,"profit":true},{"date":"2025-11-30","value":-0.34,"profit":false}]

Net Change in Cash	-	(60.20%)	(36.13%)	(662.30%)	147.48%	[{"date":"2021-11-30","value":"-","profit":true},{"date":"2022-11-30","value":-40.82,"profit":false},{"date":"2023-11-30","value":-24.5,"profit":false},{"date":"2024-11-30","value":-449.08,"profit":false},{"date":"2025-11-30","value":100,"profit":true}]

Free Cash Flow
Free Cash Flow	-	91.11%	(47.83%)	102.59%	44.88%	[{"date":"2021-11-30","value":"-","profit":true},{"date":"2022-11-30","value":88.81,"profit":true},{"date":"2023-11-30","value":-46.62,"profit":false},{"date":"2024-11-30","value":100,"profit":true},{"date":"2025-11-30","value":43.74,"profit":true}]

	Nov '24	Feb '25	May '25	Aug '25	Nov '25	TREND
Operating Activities
Net Operating Cash Flow	(48.75M)	(61.09M)	(63.16M)	(57.38M)	(67.83M)	[{"date":"2024-11-30","value":-4875100000,"profit":false},{"date":"2025-02-28","value":-6108700000,"profit":false},{"date":"2025-05-31","value":-6316100000,"profit":false},{"date":"2025-08-31","value":-5738500000,"profit":false},{"date":"2025-11-30","value":-6783200000,"profit":false}]

Investing Activities
Net Investing Cash Flow	(140.82M)	25.53M	71.50M	50.48M	346.00K	[{"date":"2024-11-30","value":-196.95,"profit":false},{"date":"2025-02-28","value":35.71,"profit":true},{"date":"2025-05-31","value":100,"profit":true},{"date":"2025-08-31","value":70.6,"profit":true},{"date":"2025-11-30","value":0.48,"profit":true}]

Financing Activities
Net Financing Cash Flow	200.52M	1.47M	6.00K	1.16M	236.01M	[{"date":"2024-11-30","value":84.96,"profit":true},{"date":"2025-02-28","value":0.62,"profit":true},{"date":"2025-05-31","value":"-","profit":true},{"date":"2025-08-31","value":0.49,"profit":true},{"date":"2025-11-30","value":100,"profit":true}]

Net Change in Cash	10.95M	(34.08M)	8.34M	(5.75M)	168.52M	[{"date":"2024-11-30","value":6.5,"profit":true},{"date":"2025-02-28","value":-20.22,"profit":false},{"date":"2025-05-31","value":4.95,"profit":true},{"date":"2025-08-31","value":-3.41,"profit":false},{"date":"2025-11-30","value":100,"profit":true}]

Free Cash Flow
Free Cash Flow	(50.86M)	(64.57M)	(65.84M)	(60.10M)	(72.96M)	[{"date":"2024-11-30","value":-5085600000,"profit":false},{"date":"2025-02-28","value":-6457200000,"profit":false},{"date":"2025-05-31","value":-6583600000,"profit":false},{"date":"2025-08-31","value":-6009600000,"profit":false},{"date":"2025-11-30","value":-7296300000,"profit":false}]

	Nov '24	Feb '25	May '25	Aug '25	Nov '25	TREND
Operating Activities
Net Operating Cash Flow	-	25.30%	3.40%	(9.14%)	18.21%	[{"date":"2024-11-30","value":"-","profit":true},{"date":"2025-02-28","value":100,"profit":true},{"date":"2025-05-31","value":13.42,"profit":true},{"date":"2025-08-31","value":-36.14,"profit":false},{"date":"2025-11-30","value":71.95,"profit":true}]

Investing Activities
Net Investing Cash Flow	-	(118.13%)	180.03%	(29.40%)	(99.31%)	[{"date":"2024-11-30","value":"-","profit":true},{"date":"2025-02-28","value":-65.62,"profit":false},{"date":"2025-05-31","value":100,"profit":true},{"date":"2025-08-31","value":-16.33,"profit":false},{"date":"2025-11-30","value":-55.17,"profit":false}]

Financing Activities
Net Financing Cash Flow	-	(99.27%)	(99.59%)	19150.00%	20333.59%	[{"date":"2024-11-30","value":"-","profit":true},{"date":"2025-02-28","value":-0.49,"profit":false},{"date":"2025-05-31","value":-0.49,"profit":false},{"date":"2025-08-31","value":94.18,"profit":true},{"date":"2025-11-30","value":100,"profit":true}]

Net Change in Cash	-	(411.16%)	(124.48%)	(168.97%)	(3028.27%)	[{"date":"2024-11-30","value":"-","profit":true},{"date":"2025-02-28","value":null,"profit":false},{"date":"2025-05-31","value":null,"profit":false},{"date":"2025-08-31","value":null,"profit":false},{"date":"2025-11-30","value":null,"profit":false}]

Free Cash Flow
Free Cash Flow	-	26.97%	1.96%	(8.72%)	21.41%	[{"date":"2024-11-30","value":"-","profit":true},{"date":"2025-02-28","value":100,"profit":true},{"date":"2025-05-31","value":7.26,"profit":true},{"date":"2025-08-31","value":-32.33,"profit":false},{"date":"2025-11-30","value":79.39,"profit":true}]

Nurix Therapeutics Inc Ratios

Nurix Therapeutics Inc Liquidity Ratios

These ratios help you determine the liquidity of the company. Higher is better.

	NRIX
Cash Ratio	6.86
Current Ratio	7.02

Nurix Therapeutics Inc Asset Efficiency Ratios

These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.

	NRIX
ROA (LTM)	-26.31%
ROE (LTM)	-49.63%

Nurix Therapeutics Inc Liability Ratios

These ratios help you understand the company's liabilities, gauging the riskiness of the investment.

	NRIX
Debt Ratio Lower is generally better. Negative is bad.	0.22
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier.	0.78

Nurix Therapeutics Inc Valuation Ratios

These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.

	NRIX
Trailing PE	NM
Forward PE	NM
P/S (TTM)	19.10
P/B	2.98
Price/FCF	NM
EV/R	12.72
EV/Ebitda	NM

Discover more

Tesla, Inc.

Apple, Inc.

Alphabet Inc. - Class A Shares

Meta Platforms Inc

Amazon.com Inc.

Microsoft Corporation

NVIDIA Corporation

Berkshire Hathaway Inc. Hld B

Eli Lilly and Company

FAQs

What is Nurix Therapeutics Inc share price today?

Nurix Therapeutics Inc (NRIX) share price today is $15.64

Can Indians buy Nurix Therapeutics Inc shares?

Yes, Indians can buy shares of Nurix Therapeutics Inc (NRIX) on Vested. To buy

from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in NRIX stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.

Can Fractional shares of Nurix Therapeutics Inc be purchased?

Yes, you can purchase fractional shares of Nurix Therapeutics Inc (NRIX) via the Vested app. You can start investing in Nurix Therapeutics Inc (NRIX) with a minimum investment of $1.

How to invest in Nurix Therapeutics Inc shares from India?

You can invest in shares of Nurix Therapeutics Inc (NRIX) via Vested in three simple steps:

Click on Sign Up or Invest in NRIX stock at the top of this page
Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
Transfer USD funds to your US Brokerage account and start investing in Nurix Therapeutics Inc shares

What is Nurix Therapeutics Inc 52-week high and low stock price?

The 52-week high price of Nurix Therapeutics Inc (NRIX) is $22.5. The 52-week low price of Nurix Therapeutics Inc (NRIX) is $8.18.

What is Nurix Therapeutics Inc price-to-earnings (P/E) ratio?

The price-to-earnings (P/E) ratio of Nurix Therapeutics Inc (NRIX) is

What is Nurix Therapeutics Inc price-to-book (P/B) ratio?

The price-to-book (P/B) ratio of Nurix Therapeutics Inc (NRIX) is 2.98

What is Nurix Therapeutics Inc dividend yield?

The dividend yield of Nurix Therapeutics Inc (NRIX) is 0.00%

What is the Market Cap of Nurix Therapeutics Inc?

The market capitalization of Nurix Therapeutics Inc (NRIX) is $1.60B

What is Nurix Therapeutics Inc's stock symbol?

The stock symbol (or ticker) of Nurix Therapeutics Inc is NRIX

How Can Investors Use Nurix Therapeutics Inc Share Price Data for Long-Term Investment Decisions?

Consider the share price of Nurix Therapeutics Inc as a long-term story and not a daily point list. The price represents a movement of the stock in both good and bad times when looked at over many years. This assists the investors to know whether Nurix Therapeutics Inc has succeeded to expand steadily and overcome market declines. With this price movement observed and the way the business is progressing, it is easier to make a decision whether the stock is worth having in the long term or not.

How does USD - INR currency movement impact returns from Nurix Therapeutics Inc shares for Indian investors?

When investing in Nurix Therapeutics Inc shares, you are not based in India then your investment is not just based on the stock price. It is also determined by the currency movement of the dollar in relation to the rupee. When you have an appreciation of the Nurix Therapeutics Inc stock and the dollar appreciation is also the same, you gain more in terms of rupees. When the rupee appreciated, it will lower your profits. This currency flow is a silent cause of great contribution to your ultimate returns over many years.

How should investors compare Nurix Therapeutics Inc share price with other stocks in the same sector?

Rather than merely checking the share price of Nurix Therapeutics Inc and comparing it with that of other stocks in the same sector, one can check how robust the business is. Investors tend to compare such aspects as profits, cash generation, and the stability of the revenues of the company. This means that Nurix Therapeutics Inc stock in most cases does not react in the same manner as other companies in the sector due to its brand and services revenue.

Feedback

Request to add more info/data

Inform about wrong info/data

Link copied

Signup to access all features and start your US investing journey!

Open your account in minutes
Take your portfolio global, starting at just $1

Get started

Add ticker to compare

Apple, Inc AAPL
Alphabet Inc. - Class A Shares GOOGL
Microsoft Corporation MSFT
Meta Platforms Inc META
Netflix, Inc. NFLX
Amazon.com Inc. AMZN
Spotify Technology SA SPOT

US Stocks & ETFs

Private Markets

Managed Portfolios (Previously Vests)

Global Funds

Global

Explore our India Diversification

INR Bonds

Alt FDs

Nurix Therapeutics Inc Share Price

Nurix Therapeutics Inc Analyst Forecast

Nurix Therapeutics Inc Share Price Chart

Nurix Therapeutics Inc Key Stock Metrics

About Nurix Therapeutics Inc, Common Stock

Nurix Therapeutics Inc Stock Returns

Nurix Therapeutics Inc Financials

Nurix Therapeutics Inc Ratios

Nurix Therapeutics Inc Liquidity Ratios

Nurix Therapeutics Inc Asset Efficiency Ratios

Nurix Therapeutics Inc Liability Ratios

Nurix Therapeutics Inc Valuation Ratios

Discover more

FAQs

Feedback

Signup to access all features and start your US investing journey!

Add ticker to compare

Company

Explore Products

Popular US Stocks ¹

Popular US ETFs ²

Curated Portfolios (Vests)

Risk Disclosure - US Markets

US Stocks & ETFs

Private Markets

Managed Portfolios (Previously Vests)

Global Funds

Global

Explore our India Diversification

INR Bonds

Alt FDs

Nurix Therapeutics Inc Share Price

Nurix Therapeutics Inc Analyst Forecast

Nurix Therapeutics Inc Share Price Chart

Nurix Therapeutics Inc Key Stock Metrics

About Nurix Therapeutics Inc, Common Stock

Nurix Therapeutics Inc Stock Returns

Nurix Therapeutics Inc Financials

Nurix Therapeutics Inc Ratios

Nurix Therapeutics Inc Liquidity Ratios

Nurix Therapeutics Inc Asset Efficiency Ratios

Nurix Therapeutics Inc Liability Ratios

Nurix Therapeutics Inc Valuation Ratios

Discover more

FAQs

Feedback

Signup to access all features and start your US investing journey!

Add ticker to compare

Popular US Stocks 1

Popular US ETFs 2

Curated Portfolios (Vests)

Popular US Stocks ¹

Popular US ETFs ²